Clinical Hypnotherapy

Clinical Hypnotherapy is an integrative psychotherapy developed by Milton Erickson in 1950. Its core mechanism: induction plus targeted suggestion modifies pain perception, habits, and anxiety responses; how much any given client responds depends heavily on baseline hypnotizability, a fairly stable trait, and whether the effect runs through a distinct trance state or through expectancy and absorption is the field's oldest unsettled argument. This catalogue links it to chronic pain, anxiety and eating disorders, typically in individual format, short-term.

By Milton Erickson Founded 1950
Key text Erickson (various)
Integrative Focus: Experiential + Skill Short-term Individual

Related condition topics

These links support exploration. They do not establish that Clinical Hypnotherapy is effective or recommended for each condition.


How Clinical Hypnotherapy works

Induction plus targeted suggestion modifies pain perception, habits, and anxiety responses; how much any given client responds depends heavily on baseline hypnotizability, a fairly stable trait, and whether the effect runs through a distinct trance state or through expectancy and absorption is the field's oldest unsettled argument

Ontology

Automatic processes (pain, anxiety, habits) can be modified through suggestion in altered states of consciousness

Therapeutic Voice

"You can hear my voice, and you can feel the chair taking your weight, and you don't have to do anything with that hand until it's ready to move on its own."

View of the Person

A divided subject. Much of what feels involuntary, including pain, habit, and dread, runs below the executive self and can be addressed directly, without the conscious agent's agreement or even its notice.

Epistemology

EmpiricistPhenomenological

Evidence

1 condition assessment available

An overall effectiveness assessment has not been completed. Completed assessments for specific populations appear below.

Condition-specific assessments

Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.

Eating Disorders

Population and scope: Patients with bulimia nervosa receiving an eight-week individualized hypnobehavioural treatment package.

Randomized studies

A 1994 trial randomized 78 participants to hypnobehavioural therapy, CBT or waiting list. Both active treatments improved bulimic behaviors relative to waiting list; no immediate between-treatment difference or abstinence advantage was found. This old, package-specific randomized evidence does not isolate hypnosis or establish effectiveness for anorexia or all eating disorders.

Source assessment dated

Guidelines and official sources (6)

6 clinical guideline checks

Read the recommendation and its scope. A source may discuss an approach without recommending it.

  • Irritable bowel syndrome in adults: diagnosis and management (CG61)

    NICE · 2008; updated 2017 · Clinical guideline · Recommendation 1.2.3.1

    Recommendation for the stated population

    NICE says to consider referral for psychological interventions including hypnotherapy. The recommendation is IBS-specific, not for pain generally.

    Scope: Adult refractory IBS continuing after 12 months without response to drug treatment.

    Source checked

  • Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder

    VA/DoD · 2023 · Clinical guideline · Recommendation 27; Table 6, p.38

    Insufficient evidence for or against

    VA/DoD finds insufficient evidence for or against hypnosis or self-hypnosis for PTSD.

    Scope: Adults with PTSD; mind-body interventions.

    Source checked

  • Management of Major Depressive Disorder

    VA/DoD · Version 4.0, February 2022; evidence through January 2021 · Clinical guideline · Recommendation 9 discussion; pp.37–38

    Discussed in the source

    The review discusses adding hypnotherapy to CBT under insufficient evidence for combining psychotherapy components. It does not recommend hypnotherapy alone or establish an added benefit.

    Scope: Adults with MDD; hypnotherapy added to CBT.

    Source checked

  • Clinical Practice Guideline for Tobacco Use Treatment

    VA/DoD · January 2026; version 3.0 · Clinical guideline · Recommendation 28; pp.38, 70–72

    Recommendation against the stated use

    VA/DoD weakly recommends against hypnotherapy as standalone cessation treatment. The recommendation does not address every adjunctive use of hypnosis or its use for other conditions.

    Scope: Hypnotherapy used alone to achieve abstinence from tobacco or nicotine.

    Source checked

  • Clinical Practice Guideline for the Management of Chronic Multisymptom Illness

    VA/DoD · May 2021; version 3.0 · Clinical guideline · Recommendation 9; pp.20, 33–34; Appendix J, p.108

    Insufficient evidence for or against

    VA/DoD finds insufficient evidence for or against guided imagery and hypnosis modalities in this population. The neutral finding does not extend to every clinical use of hypnosis.

    Scope: CMI and symptoms consistent with fibromyalgia or IBS.

    Source checked

  • Management of Type 2 Diabetes Mellitus

    VA/DoD · Version 6.0, May 2023 · Clinical guideline · Recommendation 18; pp.26,55–57

    Insufficient evidence for or against

    VA/DoD finds insufficient evidence for or against hypnosis to improve outcomes in this population. The statement does not apply to every other condition.

    Scope: Adults with type 2 diabetes and diabetes distress.

    Source checked

Recorded material under review

The existing notes below are retained separately from assessment records. These recorded claims await source checking, including study design, recommendations and numerical estimates.

Multiple RCTs for pain, IBS

Cochrane reviews for specific conditions

Strong evidence for pain management, IBS. Less evidence as standalone psychotherapy.


Training and certification

Licensed health professional (psychologist, physician, social worker, counselor, dentist, nurse). Training through ASCH (American Society of Clinical Hypnosis) or SCEH (Society for Clinical and Experimental Hypnosis).

ASCH: Certification in Clinical Hypnosis: basic workshop (20 hrs) + advanced workshop (20 hrs) + 20 hrs consultation + 2 years clinical practice with hypnosis + examination.

ASCH: 40 hrs workshop training + 20 hrs consultation + 2 years practice minimum

$1.5K–4K for workshop training; consultation fees additional; certification application ~$250

Find a trained therapist


Clinical cautions and blind spots

Assessment and precautions

Active psychosis, dissociative identity disorder without stabilization, severe PTSD where trance induction risks retraumatization, epilepsy (relative), clients with strong objections to altered states of consciousness, forensic contexts where suggestibility concerns apply

Blind spots

Suggestibility varies widely; misconceptions about control create resistance; narrow evidence base beyond pain and IBS


Philosophical roots

Erickson (utilization: work with whatever the patient brings, resistance included); Mesmer (animal magnetism, the discredited origin); Braid (renamed it hypnotism and moved the cause from a magnetic fluid to the subject's own nervous system); Janet (dissociation); James (subliminal consciousness); Hilgard (neodissociation, the hidden observer)

Compared with other approaches


Clinical Hypnotherapy in 1 Comparative Clinical Vignette

Each vignette presents the same client through multiple theoretical lenses side by side — showing how Clinical Hypnotherapy formulates presenting problems, sets treatment focus, and sounds in the consulting room compared with other approaches. This comparative pedagogy is unique to Epoché Clinical; no other clinical reference systematically formulates the same case across traditions.

Test Yourself

Ericksonian vs. direct hypnosis?

Show answer

Direct: formal commands. Ericksonian: indirect, conversational, utilizing what client brings.


Sources

Adler, S.P., et al. (2021). Clinical hypnosis for chronic pain: A meta-analysis. International Journal of Clinical and Experimental Hypnosis, 69(3), 279-309.